SCHEMBL30043535

SCHEMBL30043535

OC(=S)c1ccccc1O

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 9/20 0.56
ALDH1A1 P00352 7/20 0.56
KDM4E B2RXH2 6/20 0.56
SMN1; SMN2 Q16637 4/20 0.56
CA1 P00915 3/20 0.56
CA9 Q16790 3/20 0.56
CA12 O43570 2/20 0.56
CA2 P00918 2/20 0.56
CA4 P22748 2/20 0.56
CA14 Q9ULX7 2/20 0.56
HMGB1 P09429 1/20 0.56
CA6 P23280 1/20 0.56
CA7 P43166 1/20 0.56
NAPRT Q6XQN6 1/20 0.56
MEN1 O00255 5/20 0.54
KMT2A Q03164 5/20 0.54
HSD17B10 Q99714 7/20 0.48
MAPT P10636 5/20 0.48
ALOX15 P16050 4/20 0.48
POLB P06746 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL61048 1.00 HPGD (0.56) HPGDALDH1A1KDM4ESMN1; SMN2CA1
SCHEMBL430368 0.97 HPGD (0.54) HPGDALDH1A1KDM4ESMN1; SMN2CA1
SCHEMBL11209269 0.97 HPGD (0.54) HPGDALDH1A1KDM4ESMN1; SMN2CA1
SCHEMBL16715061 0.97 HPGD (0.54) HPGDALDH1A1KDM4ESMN1; SMN2CA1
SCHEMBL9335124 0.97 HPGD (0.54) HPGDALDH1A1KDM4ESMN1; SMN2CA1
SCHEMBL11206696 0.97 HPGD (0.54) HPGDALDH1A1KDM4ESMN1; SMN2CA1
SCHEMBL10726307 0.97 HPGD (0.54) HPGDALDH1A1KDM4ESMN1; SMN2CA1
SCHEMBL9017599 0.97 HPGD (0.54) HPGDALDH1A1KDM4ESMN1; SMN2CA1
SCHEMBL11208501 0.97 HPGD (0.54) HPGDALDH1A1KDM4ESMN1; SMN2CA1
SCHEMBL11210054 0.97 HPGD (0.54) HPGDALDH1A1KDM4ESMN1; SMN2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11591418-B2 POSS-TX nano-photo-initiator synthesis and in situ photochemical Ag nano-particle synthesis with the help of POSS-TX and wrinkled surface formation YILDIZ TEKNIK UNIVERSITESI (TR) 2023-02-28 US disclosed
US-20230050766-A1 Liquid Biopsy Method with Measuring Autofluorescence of Nucleosomes Fragmented and Released into blood from Cell Apoptosis MYTECH CO., LTD. (JP) 2023-02-16 US disclosed
EP-4083223-A1 AUTOFLUORESCENCE-BASED LIQUID BIOPSY METHOD TARGETING NUCLEOSOMES FRAGMENTED BY APOPTOSIS MYTECH Co., Ltd. (JP) 2022-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11591418-B2 POSS-TX nano-photo-initiator synthesis and in situ photochemical Ag nano-particle synthesis with the help of POSS-TX and wrinkled surface formation TBXAS1, TERB1, PARG HPGD 760/4885ALDH1A1 3804/4885KDM4E 3953/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.